Wells Fargo lowered the firm’s price target on MetLife (MET) to $95 from $97 and keeps an Overweight rating on the shares. The firm updated the company’s model post the Q2 report. MetLife’s quarter was held back by weak disability and voluntary, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MET: